Journals / Ahi Evran Tıp Dergisi / 2024 / Volume: 8 Issue: 3

Exploring Biomarkers in the Differential Diagnosis of Stroke: Insights from Ongoing Clinical Trials

İnme Ayırıcı Tanısında Kullanılan Belirteçleri Keşfetmek: Devam Eden Klinik Denemelerden İçgörüler

Serdar Özdemir(UNIVERSITY OF HEALTH SCIENCES, İSTANBUL ÜMRANİYE HEALTH RESEARCH CENTER)0000-0002-6186-6110
Hatice Şeyma Akça(KARAMANOGLU MEHMETBEY UNIVERSITY)0000-0003-2823-9577
Pages
—
Publication Date
2024-12-17
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Future studies may fill knowledge gaps in this field and clarify the role of markers in stroke diagnosis in clinical practice.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Based on insights from ongoing clinical studies, a significant step forward in the discovery of potential markers in the differential diagnosis of stroke is expected.
📊
Key Findings & Data:Developing a marker panel may help distinguish ischemic and hemorrhagic strokes and provide a faster, more accurate diagnosis.
💡
Conclusion & Impact:Future studies may fill knowledge gaps in this field and clarify the role of markers in stroke diagnosis in clinical practice.
🔬Design:Letter to Editor
📍Scope:Comprehensive Sample
⚙️Variables:stroke · biomarkers

Abstract

Based on insights from ongoing clinical studies, a significant step forward in the discovery of potential markers in the differential diagnosis of stroke is expected. Considering that the differential diagnosis of stroke can greatly influence clinical practice, the importance of these studies in identifying and validating potential diagnostic markers is high. Developing a marker panel may help distinguish ischemic and hemorrhagic strokes and provide a faster, more accurate diagnosis. However, considering heterogeneous stroke populations and different disease stages, larger samples and standardized assessment methods remain necessary. Future studies may fill knowledge gaps in this field and clarify the role of markers in stroke diagnosis in clinical practice.

Özet

Devam eden klinik çalışmaların içgörülerine dayanarak, inme ayırıcı tanısında potansiyel belirteçlerin keşfinde önemli bir adım atılmasını beklenmektedir. İnme ayırıcı tanısında klinik pratiği büyük ölçüde etkileyebileceği göz önüne alındığında, bu çalışmaların potansiyel tanısal belirteçlerin tanımlanması ve doğrulanması konusundaki önemi yüksektir. Belirteç paneli geliştirmek, iskemik ve hemorajik inmeleri ayırt etmekte ve daha hızlı, doğru bir teşhis koymakta yardımcı olabilir. Ancak, heterojen inme popülasyonları ve farklı hastalık evreleri göz önüne alındığında, daha büyük örneklemler ve standardize edilmiş değerlendirme yöntemleri gerekliliğini korumaktadır. Gelecekteki çalışmalar, bu alandaki bilgi boşluklarını doldurabilir ve inme tanısında belirteçlerin klinik uygulamadaki rolünü netleştirebilir.

🔖

Cite This Article

Özdemir, S., Akça, H. Ş. (2024). Exploring Biomarkers in the Differential Diagnosis of Stroke: Insights from Ongoing Clinical Trials. Ahi Evran Tıp Dergisi, Volume: 8 Issue: 3. https://doi.org/10.46332/aemj.1409453

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Yetiş A, Çelikbilek A, Kaya Tekeşin A, Yağiz O. Homocysteine Levels in Patients with Hemorrhagic Stroke. Ahi Evran Med J. 2023;7(1):101-105.
  2. Yew KS, Cheng E. Acute stroke diagnosis. Am Fam Physician. 2009;80(1):33-40.
  3. Simpkins AN, Janowski M, Oz HS, et al. Biomarker Application for Precision Medicine in Stroke. Transl Stroke Res. 2020;11(4):615-627.
  4. Özdemir S, Cimilli T, Onur ÖE. Relationship between the National Institutes Health Stroke Scale Score and Bispectral Index in Patients with Acute Ischemic Stroke. J Exp Clin Med. 2021;38(4):440-444.
  5. Raha O, Hall C, Malik A, et al. Advances in mechanical thrombectomy for acute ischaemic stroke. BMJ Med. 2023;2(1):e000407.
  6. Aslan T, Eroğlu SE, İslam MM, et al. Diagnostic value of ABCD2 and ABCD3-I risk scoring systems in determining one-month risk of stroke in patients with transient ischemic attack: An observational study. J. Acute Dis. 2023;12(5):192-197.
  7. Toyoda K, Yoshimura S, Nakai M, et al; Japan Stroke Data Bank Investigators. Twenty-Year Change in Severity and Outcome of Ischemic and Hemorrhagic Strokes. JAMA Neurol. 2022;79(1):61-69.
  8. Minhas JS, Moullaali TJ, Rinkel GJE, Anderson CS. Blood Pressure Management After Intracerebral and Subarachnoid Hemorrhage: The Knowns and Known Unknowns. Stroke. 2022;53(4):1065-1073.
  9. Jin J, Duan J, Du L, Xing W, Peng X, Zhao Q. Inflammation and immune cell abnormalities in intracranial aneurysm subarachnoid hemorrhage (SAH): Relevant signaling pathways and therapeutic strategies. Front Immunol. 2022;13:1027756.
  10. Jordan LC, Hillis AE. Challenges in the diagnosis and treatment of pediatric stroke. Nat Rev Neurol. 2011;7(4):199-208.